SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Watch highlights from the Virtual Biopharmaceutical Summit 2021

SelectScience

Top talks from world-leading scientists and the latest resources in the field are now available on demand

15 Nov 2021
Ellie Abbott
Biochemist

Editorial article

Biopharmaceutical summit 2021 logo
Explore the latest biopharmaceutical research and techniques here

Scientists from across the globe connected with world-class speakers and leading manufacturers online to showcase their research and share technology solutions in the field of biopharmaceuticals.

Following the success of last year's inaugural Biopharmaceutical Summit, the Virtual Biopharmaceutical Summit 2021 showcased hot topics spanning cell and gene therapy, biopharmaceutical characterization, nanomedicines, COVID-19, and more.

The free-to-attend SelectScience Virtual Summits offer the opportunity to bring together thousands of scientists from across the globe to explore major developments in the field. The platform featured renowned speakers, interactive booths, resource hubs from leading brands, and opportunities for scientists and manufacturers to connect. In addition, this year scientists were invited to take part in the event by submitting a poster or abstract of their latest biopharma research to be showcased in the new poster hall feature. Attendees were able to view academic posters submitted by our global scientific community, leave comments, and ask questions.

Summit speaker, Dr. Jared Auclair, from the Northeastern University, described why such events are important: “Continued communication and collaboration through events like these has never been more important than it is today as we continue to navigate the global COVID19 pandemic, especially in order to ensure high-quality medicines and vaccines reach patients.”

A total of 16 compelling presentations each drew in large crowds of live attendees, as did the new poster hall.

Just a few of the talks now available to watch on demand include:

  • Keynote: Exploring disulfide bonds and variants as it relates to product quality - Dr. Andrew Mahan, Janssen: Pharmaceutical Companies of Johnson & Johnson
  • Keynote: Challenges of Phase III clinical trial product manufacturing in cell and gene therapy - Prof. Gerhard Bauer, University of California Davis
  • Biopharmaceuticals – ensuring the quality of your medications - Dr. Jared R. Auclair, Northeastern University
  • Flexible nanoscale options for IP drug delivery: Targeting high-grade serous ovarian cancer - Dr. Lewis Francis, Swansea University
  • Quantitation of particle profiles in biologics and cell therapies - Christine Probst, KBI Biopharma, Inc.
  • Optimizing protein expression: Glycosylation, titer and development - Bjørn Gunnar Voldborg, Technical University of Denmark
  • Protein LC-MS evolved: Characterization tools for new assays in bioanalysis - Dr. John Kellie, GSK
Biopharma summit speakers
Summit speakers (l-r): Prof. Gerhard Bauer, Dr. Lewis Francis, Bjørn Gunnar Voldborg, Christine Probst, Dr. John Kellie, Dr. Jared R. Auclair, and Dr. Andrew Mahan

The Virtual Summit also featured live Q&A sessions, a product launch area, and 1-on-1 chat facilities to prompt and enable collaboration. Summit speaker, Christine Probst, from KBI Biopharma, Inc., said: "This conference is an excellent forum to learn about the latest research and network with other scientists".

A number of leading manufacturers showcased their latest technologies available in the field, including Horizon, Sartorius, Agilent, Tecan, Metrohm, PharmaFluidics, Luminex, and PerkinElmer. Attendees were also able to collect a virtual swag bag of useful resources completely free of charge — these are also available on demand in the event hall, for a limited time only. Featured highlights from the summit include:

  • An improved workflow for profiling and quantitation of sialic acids in biotherapeutics: Download »
  • Resolvex A200: Automated positive pressure processor: Download »
  • Suspension bead arrays for biomarker discovery and validation: Download »
  • Glycosylation analysis of therapeutic enzymes using µPAC capLC-MS and all-ion fragmentation: Download »
  • Successful RNA interference experiments in difficult-to-transfect cell lines: Download »
Images of 4 Biopharma Summit Posters
New feature: A selection of posters submitted to the Biopharmaceutical Summit on display at the poster hall

Missed the live event? Don’t worry – all presentations are now available to view on demand>>

Links

SelectScienceCompany website

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Cell / Tissue CultureCell culture or tissue culture is used to study the biology of cells or tissues and to isolate cellular products in an environment which can be manipulated and well defined. Accurately control your culture environment with bioreactors or culture incubators, bind your cells to a surface or together with an extracellular matrix. Distinguish cell types with differential media or proliferate cells with certain characteristics using selective media. Enrich your media with supplements such as growth factors, sera and vitamins. Find the best cell and tissue culture products, kits and equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.ImmunoassayImmunoassays are laboratory tests that utilize antibody-antigen interactions to detect specific substances. They are widely used in diagnostics for detecting diseases, drug testing, and environmental monitoring. These assays offer rapid, sensitive, and precise detection of biomarkers, making them invaluable in clinical and research labs. Browse our peer-reviewed product directory to compare immunoassay systems, read user reviews, and get pricing directly from manufacturers.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.Cell TherapyCell therapy involves using living cells to treat diseases, often by replacing damaged cells or stimulating regeneration. Stem cell therapy and CAR-T cell therapy are examples of cutting-edge treatments in regenerative medicine and cancer immunotherapy. Browse our peer-reviewed product directory to find the best cell therapy tools, compare products, check reviews, and get pricing directly from manufacturers.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Gene TherapyGene therapy is a technique that modifies or replaces genes within an individual's cells to treat or prevent diseases. This approach holds potential for curing genetic disorders, cancers, and certain viral infections. Advances in gene editing technologies like CRISPR are driving the growth of gene therapy. Explore gene therapy tools and technologies in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Cancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.

Related articles